Aether Industries Ltd

Aether Industri. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aether Industries Ltd

₹ 1,540 3.27%
31 Jul - close price
aether.co.in BSE: 543534 NSE: AETHER
About

Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]

Key Points

Business Segments[1] [2]
a) Contract / Exclusive Manufacturing (46% in FY26 vs 31% in FY25): [3]
The company produces products for its customers under contractual supply agreements that can be either short-term or long-term, and may be exclusive or non-exclusive in nature. It has entered into long-term take-or-pay contracts with global clients such as Baker Hughes, SEQENS, and Saudi Aramco.

Website BSE NSE
  • Market Cap ₹ 20,432 Cr.
  • Current Price ₹ 1,540
  • High / Low ₹ 1,614 / 723
  • Stock P/E 85.2
  • Book Value ₹ 185
  • Dividend Yield 0.00 %
  • ROCE 11.9 %
  • ROE 9.66 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 8.32 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 7.91% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 BSE Commodities BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
161 164 155 118 180 199 220 240 257 280 319 305 327
116 118 124 107 137 145 155 161 175 192 207 222 224
Operating Profit 45 46 31 10 43 54 65 80 81 88 112 83 103
OPM % 28% 28% 20% 9% 24% 27% 29% 33% 32% 31% 35% 27% 31%
2 14 5 4 9 8 11 2 -1 6 -4 10 8
Interest 1 2 2 4 3 2 3 5 5 3 4 6 6
Depreciation 9 10 10 10 10 11 11 13 14 17 17 18 21
Profit before tax 37 49 24 0 39 49 61 64 62 74 87 68 83
Tax % 19% 25% 27% 486% 24% 28% 29% 21% 24% 27% 26% 21% 25%
30 37 17 -1 30 35 43 50 47 54 64 54 63
EPS in Rs 2.25 2.77 1.31 -0.11 2.26 2.63 3.27 3.79 3.55 4.07 4.86 4.07 4.73
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
590 651 598 839 1,160 1,231
422 465 466 598 796 845
Operating Profit 168 186 132 241 364 386
OPM % 28% 29% 22% 29% 31% 31%
7 17 25 30 12 20
Interest 13 5 9 13 18 19
Depreciation 15 23 40 45 66 74
Profit before tax 146 174 110 213 291 313
Tax % 26% 25% 25% 26% 25%
109 130 82 158 219 235
EPS in Rs 9.67 10.47 6.22 11.95 16.54 17.73
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 34%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 20%
TTM: 30%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 14%
1 Year: 104%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 8%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 113 125 133 133 133
Reserves 274 1,120 1,931 2,093 2,323
291 16 183 200 458
92 120 154 218 288
Total Liabilities 770 1,380 2,401 2,644 3,201
257 646 853 1,117 1,506
CWIP 58 37 232 363 506
Investments 17 1 0 0 0
438 695 1,315 1,163 1,189
Total Assets 770 1,380 2,401 2,644 3,201

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-5 -7 -16 100 142
-151 -348 -424 -418 -619
169 439 894 2 244
Net Cash Flow 12 84 453 -316 -233
Free Cash Flow -157 -363 -444 -352 -390
CFO/OP 17% 14% 1% 57% 54%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 101 145 142 126 123
Inventory Days 221 301 411 356 326
Days Payable 95 99 124 114 120
Cash Conversion Cycle 227 348 429 367 330
Working Capital Days 82 268 279 238 160
ROCE % 18% 7% 10% 12%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
CRAMS Revenue as % of Total Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
R&D as % of Revenue
%
R&D Expenditure
INR MM
Capacity Utilization - Manufacturing Facility 2 (Site 2)
%
Products in Portfolio
count
Total Customers
count
Capacity Utilization - Manufacturing Facility 3 (Site 3)
%
Capacity Utilization - Manufacturing Facility 4 (Site 4)
%
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
81.80% 81.79% 81.79% 81.79% 81.78% 81.77% 81.77% 74.99% 74.99% 74.98% 74.94% 74.92%
2.44% 1.97% 2.22% 2.90% 3.17% 3.32% 3.33% 5.03% 4.64% 5.81% 6.29% 7.42%
12.99% 11.79% 11.82% 11.55% 11.63% 11.49% 11.43% 13.41% 12.97% 12.25% 12.66% 10.49%
2.76% 4.44% 4.16% 3.74% 3.40% 3.41% 3.47% 6.55% 7.39% 6.96% 6.10% 7.17%
No. of Shareholders 60,46684,00078,65571,68367,25166,67764,03472,62873,80667,80665,56265,336

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls